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HIV infection and HIV drug therapies result in physical and psychological challenges to those living with HIV.
These conditions contribute to decreased functional aerobic capacity (FAC). The aim of this study was to
determine the effects of a combined moderate-intensity aerobic and resistance exercise intervention on the FAC
of HIV-infected individuals. Forty HIV-infected individuals were randomized to an exercise group (EX) who
completed six weeks of moderate-intensity exercise training, or to a control group (CON) that did not receive the
exercise intervention. Twice weekly, the EX group completed 30 minutes of moderate-intensity aerobic training
followed by moderate-intensity resistance training. Prior to, and following, the intervention the FAC for each
subject was determined by graded exercise treadmill stress test (GXT). At baseline testing, the mean FAC as
determined by treadmill time-based estimation of maximal oxygen consumption was 25% below age-predicted
values, a level of reduction indicating the presence of functional aerobic impairment (FAI). Following the
intervention, the EX had a significant increase in time to fatigue and estimated VO2 max (pB.001). Further, FAI
was eliminated (1% above age predicted values) during the exercise training. The EX group also experienced
decreased heart rates during Stages 1 (p.02), 2 (p.01), 4 (p.05) and 6 (p.02) of the GXT. The CON had
no significant changes during the intervention period. These data indicate that six weeks of combined moderate-
intensity aerobic and resistance training can improve FAC and eliminate FAI in those with HIV. Results suggest
that the functional limitations common in HIV-infected individuals are due in part to detraining that is reversible
through moderate exercise adherence.
Keywords: VO2; heart rate; functional aerobic capacity; graded exercise test
Introduction
People of all ages infected with HIV have been shown
routinely to have abnormally low functional capa-
cities, expressed as lowered capacity to utilize oxygen
(VO2) and perform physical work (Keyser, Peralta,
Cade, Miller, & Anixt, 2000). The reduction of 25%
or greater in age-predicted maximal capacity to use
oxygen is termed functional aerobic impairment
(FAI). Tests of an individual’s ability to use oxygen,
functional aerobic capacity (FAC), have shown those
infected with HIV to have maximal VO2 of 2444%
below their age-predicted normal values (Lox, Ma-
Culey, & Tucker, 1996; MacArthur, Levine, & Birk,
1993). While it is likely that the etiology of this
reduced work capacity is multifactorial, the sparse
evidence available suggests that moderate to high
intensity training is effective in improving the FAC of
HIV-positive persons. Most training protocols have
exercised subjects at 70% or greater of VO2 max,
typically three times a week for 60 minutes per
session. Additionally, only three studies (Grinspoon
et al., 2000; Robinson, Quinn, & Rimmer, 2007;
Smith et al., 2001) have been conducted since the
establishment of highly active antiretroviral therapy
(HAART) as the standard of care, with six additional
studies (Baigis et al., 2002; Lox et al., 1996;
MacArthur et al., 1993; Perna et al., 1999; Stringer,
Berezovskaya, O’Brien, Beck, & Casaburi, 1998;
Terry et al., 2006) including subjects on some type
of antiretroviral therapy. Given the potential negative
impact of the drug side-effects on heart disease risk
factors and cardiovascular function, the results from
these early studies should be viewed cautiously and
need to be revisited. Research has shown exercise to
be safe in this population (Bopp, Phillips, Fulk, &
Hand, 2003). Low to moderate-intensity exercise does
not alter CD4 cell counts or viral load, nor does it
increase the prevalence of opportunistic infections
(Dudgeon, Phillips, Bopp, & Hand, 2004). Addition-
ally, no reports of adverse side-effects to exercise
interventions have been reported.
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The effects of training in HIV-positive persons
can include beneficial changes in body composition
and muscular strength. Increases in lean tissue mass
are positively correlated with slowed disease progres-
sion and decreased mortality in HIV disease (Wheeler
et al., 1998). Thus, resistance training, resulting in
lean tissue mass and muscular strength increases in
healthy and diseased populations (Castaneda et al.,
2001; Hakkinen, Sokka, Kotaniemi, & Hannonen,
2001; Hurley et al., 1995), has been prescribed to
HIV-positive persons, with varying results. However,
it appears that high-intensity resistance training may
elicit favorable results in HIV-positive persons (Rou-
benoff et al., 1999; Roubenoff & Wilson, 2001). It is
unknown if low- to moderate-intensity resistance
training has similar effects.
Thus, studies of combined aerobic and resistance
exercise training may result in both cardiovascular
and musculoskeletal adaptations, making them more
appealing than either mode alone. Three studies
(Grinspoon et al., 2000; Rigsby, Dishman, Jackson,
Maclean, & Raven, 1992; Robinson et al., 2007) have
implemented resistance training along with aerobic
exercise training in HIV-positive populations. Each
reported increases in FAC similar to exercise regi-
mens consisting of only aerobic training, and in-
creases in strength greater than that produced by the
aerobic regimens. However, these studies utilized
high-intensity resistance training, which often results
in poor exercise adherence due to muscle soreness and
increased risk of injury in untrained individuals. By
comparison to these previous studies, the aim of the
present study was to determine the effects of a modest
amount of moderate-intensity, resistance and aerobic
exercise training on markers of FAC in HIV-positive
persons. Another aim was to implement the current
physical activity recommendations of the American
College of Sports Medicine into a deconditioned
population and to test its effectiveness in this
population.
Methods
Sample
Forty HIV-infected men and women were recruited
from local HIV/AIDS service organizations in the
Columbia, SC metropolitan area. All HIV-infected
individuals were over 18 years of age, free of any
known opportunistic infections and physically able to
complete the exercise intervention. No person was
excluded based on ethnicity or gender.
Individuals were excluded from the study if: (1)
their medical history revealed current opportunistic
infection(s); (2) were currently using, or a past
receiver of, hormone therapy; (3) scored five or
greater on the Drug Abuse Screening Test (DAST)
and/or the Michigan Alcohol Screening Test
(MAST); (4) reported current involvement in a
structured exercise program; or (5) any contraindica-
tions for testing, as specified by the American College
of Sports Medicine (American College of Sports
Medicine, 2000), were identified.
Procedure
All procedures, including testing and exercise train-
ing, were completed in the Clinical Exercise Research
Center (CERC) in the Department of Exercise
Science at the University of South Carolina. After
signing the informed consent statement, subjects were
assigned an identification number and then assisted in
completing a demographic data sheet (age, race,
gender, CDC-defined disease stage, current health
status) and a cardiovascular risk factor survey
addressing current medications (including HIV med-
ications), family history of cardiovascular disease,
smoking habits, physical activity habits, significant
health concerns (other than HIV-infection) and other
pertinent health information. Medical personnel
reviewed the completed risk factor survey and
obtained resting blood pressure (BP) and heart rate
(HR) for each subject. If no contraindications for
exercise stress testing were identified, subjects were
cleared to receive a graded exercise treadmill stress
test (GXT). Following successful completion of the
GXT, subjects were randomized, via random number
table, to either the intervention exercise (EX) group
or a non-intervention control (CON) group. The
screening survey and the GXT were repeated in the
same fashion, two-to-four-days post-intervention.
The Office of Research Compliance at the University
of South Carolina approved the study and its
procedures.
Graded Exercise Treadmill Stress Test
A trained exercise physiologist prepared eligible
subjects for the GXT and a standard 12-lead electro-
cardiograph (ECG) was performed. Subjects sat
quietly while medical personnel examined the real-
time resting ECG, HR and BP. Once cleared for
participation, the exercise physiologist administered
the GXT using the Modified Bruce protocol on
motorized Trackmaster treadmills (Full Vision, Inc.,
Newton, KS). All subjects exercised to volitional
fatigue, followed by continued walking at a slow pace
until HR and BP returned to baseline levels. Heart
rate, BP, and treadmill total time were recorded at
each stage of the protocol. Staff were blinded to
group assignment.
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The Modified Bruce GXT begins at a speed of 1.7
mph at 0% grade for three minutes then progresses to
1.7 mph at 5% grade for three minutes. After this
stage, the protocol is identical to that of the Bruce
Protocol. The Modified Bruce Protocol was used due
to its lower initial intensity for this generally decondi-
tioned population. Previous research has shown a
high correlation between the Modified Bruce and
Bruce protocols for HR responses (r0.97) and peak
VO2 measurements (r0.72) (McInnis & Balady,
1994).
Calculations for VO2 peak and functional aerobic
impairment
Estimated VO2 peak was calculated from the tread-
mill total time. No universally accepted VO2 peak
calculation is available for the Modified Bruce
Protocol, so 360 seconds (the equivalent of the first
two stages that are absent from the Bruce protocol)
were subtracted from each subject’s treadmill total
time. Total time on the treadmill in minutes was
calculated from the total seconds (seconds/60). The
time in minutes (T) was placed into the following
gender specific equations that have been validated for
estimating VO2 peak from treadmill time during the
Bruce Protocol (Foster et al., 1984):
 Males: 14.76-(1.379 * T)(0.451 * T2)
 (0.012 * T3)
 Females: (4.38 * T)  3.9
Predicted VO2 max was calculated using the follow-
ing age- and gender-specific formulas (Bruce, Ku-
sumi, & Hosmer, 1973):
 Males: 69.7  (0.612 * age in years)
 Females: 42.9  (0.312 * age in years)
Functional aerobic impairment (FAI) was obtained
with the following formula:
 %FAI[(predicted V02  observed V02)/predicted
V02] * 100
Aerobic exercise intervention
Exercise intervention subjects completed 30 minutes
of aerobic exercise treadmill training in the intensity
range of 5070% of their age-predicted maximum
HR (220-age in years) twice weekly, for six weeks.
Heart rate was monitored using Polar Heart Rate
Monitors. Each treadmill session consisted of a
5-minute warm-up period, followed by 30 minutes
of training within the intensity range and then a 35
minute cool-down. Treadmill speed and grade were
adjusted during each session to keep subjects within
their prescribed intensity range.
Resistance exercise intervention
Following the aerobic training session, EX subjects
completed upper-body and lower-body resistance
training in approximately 20 minutes. Movements
targeting the chest, upper back and triceps muscles
were performed on plate-loaded Hammer Strength
machines (Cincinnati, OH), the upper anterior and
posterior legs on Life Circuit machines (Life Fitness,
Irvine, CA) and the biceps brachii and deltoids using
free weights. Subjects were given approximately one-
minute recovery time between exercises. Resistance
was adjusted so that each subject could complete one
set of 12 repetitions for each exercise while maintain-
ing proper form. As strength increased, resistance was
changed to keep the subjects at their prescribed
training intensity. Sessions were separated by at least
48 hours of recovery and lasted one hour in total
duration.
Control group
Control group subjects came to the CERC for the
same amount of time and weekly frequency as the EX
subjects. The CON participants were allowed to read
a book, talk or watch television. They were allowed
to participate in the training regimen after completion
of the CON protocol. Performance data from these
subjects during the EX intervention are not included
in the data analysis.
Statistical analysis
Sample size was based on previous studies of the
same population. Repeated measures analysis of
variance (ANOVA) was used to compare physiologi-
cal and performance variables (HR, VO2, time to
fatigue) within groups. Variables at specific time-
points were compared between groups using AN-
OVA. The significance level was set at a.05 and a
Tukey post-hoc analysis of treatment means was used
to identify differences between groups. All values are
expressed as mean9standard error (SE). No ancillary
analyses were performed.
Results
Demographic data
Seventy-seven subjects were cleared for study parti-
cipation and 11 subjects were excluded at screening
based on the above mentioned criteria. With over-
sampling of the control group, forty-four subjects
were randomly assigned to the control group and 30
subjects were randomized to the exercise group.
Twenty-one subjects (seven women) in the EX inter-
vention and nineteen subjects (three women) in the
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CON group finished and completed all sessions in the
study. Demographic data for each group is presented
in Table 1. Thirteen EX group subjects were receiving
HAART, three were not and five refused to answer.
Sixteen individuals in the CON group were receiving
HAART, one was not and two refused to answer.
The mean age of the EX and CON group was not
different (41.292.3 years and 42.491.4 years, re-
spectively). The ethnic compositions of the groups
were similar with the EX group having 14 African
Americans and the CON group 13. Fifteen EX group
subjects self-classified themselves as HIV-positive
asymptomatic, according to the 1993 Centers for
Disease Control and Prevention criteria, while 13
CON group subjects were self-classified as HIV-
positive asymptomatic. No adverse events occurred
to any of the subjects.
Functional aerobic capacity
Figure 1 illustrates the effect of training on estimated
VO2 max and treadmill time. Baseline analysis
revealed that the estimated VO2 peak of all 40
subjects, completing the study, was 30.591.8 ml/kg/
min. The EX group had an estimated VO2 peak of
31.692.1 ml/kg/min after spending 14.290.8 min-
utes on the treadmill, which was not different from
the 29.490.3 ml/kg/min and 14.290.2 minutes of the
CON group. There were no differences in estimated
treadmill time or VO2 peak between the 7 females
(8.192.3 minutes; 31.290.3 ml/kg/min) and 14 males
(9.193.0 minutes; 31.690.4 ml/kg/min) in the EX
group. The male controls had a significantly higher
treadmill time and estimated VO2 peak (8.794.0
minutes; 30.490.8 ml/kg/min) than did the females
(5.691.7 minutes; 20.590.1 ml/kg/min). There was
no difference in baseline treadmill time or estimated
VO2 peak between those 30 subjects taking HAART
(8.693.3 minutes; 30.390.6 ml/kg/min) and those 11
who were not or did not answer (8.393.6 minutes ;
30.690.7 ml/kg/min) .
Compared to pre-treatment values, the EX group
increased treadmill time to 16.990.5 minutes (pB
.01) with a 21% increase in estimated VO2 peak to
39.991.9 ml/kg/min (pB.01). The female exercisers
improved by 24% (9.8 ml/kg/min increase) and
increased treadmill time to 10.392.0 minutes, while
the males improved by 20% (7.4 ml/kg/min) and
increased treadmill time to 11.292.3 minutes. No
difference (p.72) was detected in response to
training between those receiving HAART (7.691.0
Table 1. Self-reported demographic data of subjects who
completed the 6-week study.
Variable
Exercise
group
Control
group
Age 41.292.3 42.491.4
Male 14 16
Female 7 3
African American 14 13
Caucasian 5 6
Other 2 
ART yes 13 16
ART no 3 1
Did not answer 5 2
HIV-positive asymptomatic 15 13
HIV-positive symptomatic 1 1
AIDS 5 5
Note: HIV status is based on 1993 CDC criteria.
‘ART Yes’ refers to those subjects who reported taking at least one
antiretroviral therapy during the study period.
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Figure 1. Effect of training on estimated VO2 and time on treadmill.
$ versus control and *versus baseline.
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ml/kg/min improvement and treadmill time of 9.49
3.5 minutes) and those not (7.991.1 ml/kg/min and
10.193.0 minutes). No differences from pretreatment
values were observed in treadmill time (14.890.8
minutes) or estimated VO2 peak (29.492.7 ml/kg/
min) in the CON group post-intervention.
Functional aerobic impairment
The age-predicted VO2 peak for all the subjects was
40.591.1 ml/kg/min, thus the subject pool had a
baseline FAI of 24.6%, with the EX group a FAI of
20%, compared to CON group’s 29.2% (Figure 2).
The female exercisers exhibited no FAI at pretest
(2.8% above predicted), while the males showed a
27% FAI. The CON group did not change FAC or
FAI following the intervention. However, the EX
group’s improved FAC indicated a complete elimina-
tion of any FAI and raised the group’s FAC to 1.2%
above the predicted maximum at study conclusion.
The female exercisers finished with a FAC 35%
above predicted max, while the males improved to
11% impairment.
Heart rate
Heart rate was collected for each subject at rest,
during each minute of the GXT and at peak work-
load. There were no differences between groups in
percent of age-predicted maximum heart rate
(APMHR) achieved during the pretests (EX: 87%9
14% versus CON: 83%915%) or during the posttest
(EX: 86%910% versus CON: 83%912%).
Figure 3’s upper and lower panels illustrate changes
in HR as GXT intensity increased from rest to peak
exercise. Following the study, the EX group de-
creased HR at stages 1 (p.02), 2 (p.01), 4 (p
.05) and 6 (p.02) and showed a trend for a
decreased resting HR (p.07). No HR changes
were observed in the CON group. Percent of max-
imum HR achieved at baseline was not different
between the men (83%915%) and women (94%9
9%) in the EX group, nor did it differ at post-testing
(85%911% versus 89%97%, respectively). Addi-
tionally, no change was seen in maximum HR at the
posttest for the EX group (15493 versus 15494) or
the CON group (14297 versus 14796).
Discussion
The baseline estimated VO2 peak for this sample was
30.591.8 ml/kg/min, signifying FAI as the partici-
pants achieved only 75% age-predicted VO2 max
(40.591.1 ml/kg/min). However, following the
6-week intervention, the EX group’s VO2 peak
increased 26% (31.692.1 ml/kg/min to 39.991.9
ml/kg/min), abolishing the FAI present at pre-inter-
vention, and placed them 1.2% above age-predicted
values. This improvement was further demonstrated
by a significant reduction in peak HR during four of
the six GXT stages. Finally, the intervention was well
tolerated, indicated by the EX group’s 70% comple-
tion rate.
Research in HIV-positive populations has re-
vealed estimated VO2 max values below 30 ml/kg/
min in untrained persons (Keyser et al., 2000;
Prentiss, Power, Balmas, Tzuang, & Israelski, 2004;
Stringer et al., 1998; Thoni et al., 2002), indicating
low FAC. Higher-intensity aerobic exercise training
(75% VO2 max) has been effective at improving
FAC, although most data were reported pre-HAART
(LaPerriere et al., 1990; MacArthur et al., 1993;
Stringer et al., 1998) many have erroneously reported
peak measurements as maximal values. In most cases,
VO2 peak is the appropriate term as few tests achieve
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Figure 2. Effect of training on functional aerobic impairment.
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the criteria for a true maximal GXT. Our experience
is that only perhaps 1% of the HIV-infected popula-
tion can achieve a true maximal GXT (a VO2 plateau
with increasing workload), due to the severe physical
deconditioning seen in this population.
The combined group’s pre-training estimated VO2
peak of 30.591.8 ml/kg/min is comparable to other
FAC values reported involving this population.
Studies utilizing electrically braked cycle ergometers
noted VO2 max baseline values of 25.2 ml/kg/min to
30 ml/kg/min (Rigsby et al., 1992; Stringer et al.,1998;
Thoni et al., 2002). Baseline VO2 max estimates using
treadmill protocols are comparable to bike tests and
our results, and ranging from 26 ml/kg/min and 33.2
ml/kg/min (Cade, Fantry, Nabar, Shaw, & Keyser,
2003; MacArthur et al., 1993). Estimated VO2 peaks
were similar for both genders in our experimental
group, though the females were above the gender and
age-specific predicted values while males were below.
Although not specifically addressed, literature
suggests significant FAI in the HIV-positive popula-
tion. Stringer et al. (1998) reported that the 34
subjects in their study exhibited values at 85%
predicted VO2 max. Keyser et al. (2000) showed
that a group of 17 young HIV-positive persons (189
2 years old; 12 females) all had FAI, with VO2 max
values (42919%) less than predicted. Seventy-four
percent (29 of 39) of the subjects in our study
exhibited FAI, with a mean percent impairment of
2591.2%. However, when examining only those with
impairment, the mean was 36.790.2%. Interestingly,
only 3 of the 10 females in our study exhibited FAI at
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baseline, and were 2.790.8% above predicted FAC
as a group. Conversely, 26 of the 32 men had FAI,
with a group mean of 29.192.4%. With a high level
of confidence in the gender-specific functional capa-
city equations (Keyser et al., 2000), the data suggest
that the female participants were either less affected
by their infection (i.e. fewer symptoms or less severe)
or their lifestyles facilitated a higher level of activity.
This potential gender disparity demands further
investigation.
A crucial question regarding exercise capacity in
HIV-positive persons is their ability to adapt to
training stimuli. Increasing evidence suggests that
improved FAC can be expected with 12 weeks or
more of training. MacArthur et al. (1993) found that
24 weeks of moderate- (5060% VO2 max) and high-
intensity (7585% VO2 max) training improved FAC
of HIV-positive persons in each group (n3) by
5.8 ml/kg/min and 10.1 ml/kg/min respectively. Also,
subjects (n19) completing 45 minutes of training at
ventilatory threshold (the upper limit of aerobic
exercise) on a stationary cycle for 16 weeks (2x/
week) saw a significant 2.6 ml/kg/min increase in VO2
max (Thoni et al., 2002). Further, training one hour
per day, three days per week for 12 weeks at 80% HR
reserve (the difference between one’s resting HR and
maximum HR) on a stationary cycle resulted in a 5
ml/kg/min increase in 37 males (Rigsby et al., 1992).
However, Smith et al. (2001) showed a non-signifi-
cant 2.6 ml/kg/min increase in VO2 max following
12-weeks of training (18 subjects; 20 min on treadmill
and 10 min on stationary bike/stair stepper/ cross-
country machines), three times per week at 6080%
VO2 max.
Training durations less than three months have
been used infrequently. Stringer et al. (1998) aero-
bically trained a group of HIV-positive subjects (n
9) at 80% pre-intervention VO2 max for 3040 min,
three times per week for six weeks, eliciting a 1394%
increase in FAC, while a group (n9) training at
45% VO2 max (six weeks) showed no improvement.
Results from our low-volume, short-term (six weeks),
moderate-intensity (5070% APMHR) intervention
using aerobic and resistance activities yielded a 26%
increase in estimated VO2 peak, which is greater than
other studies of similar duration and comparable to
higher-intensity interventions of longer duration.
In comparison to the other studies that utilized a
combination of aerobic and resistance training,
Robinson et al. (2007) trained subjects at an intensity
between 70 and 80% VO2 max for 20 minutes, 3 times
a week for 16 weeks, but only saw an increase of 10%
in VO2. Robinson’s study also utilized a resistance
program of two times a week consisting of one set of
810 repetitions done at 80% of their one repetition
maximum. Rigsby et al.’s (1992) study consisted of
aerobic training, three days a week, for 12 weeks at a
training intensity between 60 and 80% VO2 max and
a resistance regimen of three sets of repetitions, with
repetitions varying from 618 repetitions per set.
They showed a 17% increase in VO2. Grinspoon
et al. (2002) also completed a study utilizing a
combination of aerobic and resistance training, but
did not report any VO2 values. When compared to
our study’s results, it can be suggested that improve-
ments in FAC can be seen in HIV-positive persons at
lesser intensities than have been tested previously,
and can be experienced with programs including
resistance training. The minimum duration of an
effective exercise bout at different intensities remains
to be determined.
Exercise training studies involving HIV-positive
persons have generally not included HR data in their
results. The change in HR during aerobic exercise is
tightly coupled to increasing VO2 as intensity rises.
Therefore, HR is a useful measure when comparing
results across studies not reporting VO2 measure-
ments. Additionally, a foundational marker of im-
proved cardiovascular function is decreased HR at
absolute submaximal work rates, the well-known
training bradycardia effect. In this study, we report
reduced HR changes in HIV-positive subjects during
multiple stages of a GXT. We observed significantly
decreased HR at GXT Stages 1, 2, 4, and 6. Only two
other studies have recorded such decreases following
training, and these were of longer duration (1224
weeks), consisted of less subjects (6 and 13) and
conducted pre-HAART (MacArthur et al., 1993;
Rigsby et al., 1992).
This study also provided evidence that the Mod-
ified Bruce protocol is an appropriate GXT for the
HIV-positive population. Prior to the study, this
protocol was chosen over the Bruce protocol because
it begins at a lower intensity and is less physically
demanding. Buchfuhrer et al. (1983) suggested that
FAC tests should last between 8 and 17 minutes, due
to an increase in measurement error with tests lasting
longer. Our average time of completion (14.590.6
min) was within the ‘optimal’ range suggested by
Buchfuhrer et al. with eight tests longer than 17
minutes, and one test less than eight minutes. Had the
Bruce protocol been used, nearly half the subjects
(n19) would have been below the optimal range.
A major limitation of many studies involving
training in HIV-positive populations is small sample
sizes (MacArthur et al., 1993; Rigsby et al., 1992).
While the difficulty in retaining subjects is recog-
nized, the lack of adequate sample sizes (resulting in
low statistical power) is of concern and makes
interpretation difficult. Due to this small sample
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size, we did not perform an intent to treat analysis.
Difficulties facing this population include inadequate
transportation, poverty and opportunistic infections,
possibly explaining high attrition rates in other
studies. Our study achieved a 70% completion rate.
Dropouts that were contacted reported no adverse
signs or symptoms related to the exercise training and
indicated that they voluntarily withdrew due to other
factors. It should be noted that the twice-weekly
sessions made this study less burdensome than studies
using 35 sessions per week, perhaps explaining
greater success in subject retention. Additionally,
the moderate-intensity nature of this intervention
would theoretically increase retention rates, as it
would lessen the discomfort and fatigue associated
with exercise of higher intensities. Another limitation
was that we only asked if the subjects were on
HAART therapy and not what type of specific classes
of HAART medications they were taking.
Conclusion
This study confirmed the presence of decreased FAC
in HIV-positive men and demonstrated a gender
difference in HIV-associated FAI. Further, a training
effect was apparent in both genders, showing en-
hanced FAC, decreased FAI and decreased HR at
absolute submaximal workloads. The Modified Bruce
protocol was appropriate for this population, given
80% of the subjects completed the GXT within an
accepted ‘optimal’ range. Additionally, it appears
that HIV-infected persons adhere well to low-volume,
moderate-intensity training, as 73% of the exercising
subjects completed this intervention. Finally, our
findings suggest that HIV-infected persons can ex-
perience beneficial cardiovascular adaptations from
short-duration training combining low-volume aero-
bic and resistance movements at moderate-intensity.
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